Skip to main content
CHA Vaccine Research Institute (KOSDAQ:261780)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,575.00
-135.00 (-4.98%)
At close: Mar 9, 2026

KOSDAQ:261780 Revenue

CHA Vaccine Research Institute had revenue of 158.62M KRW in the twelve months ending September 30, 2025, down -57.21% year-over-year. In the year 2024, CHA Vaccine Research Institute had annual revenue of 370.66M with 26.02% growth.

Revenue (ttm)
158.62M
Revenue Growth
-57.21%
P/S Ratio
436.14
Revenue / Employee
n/a
Employees
n/a
Market Cap
69.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024370.66M76.53M26.02%
Dec 31, 2023294.12M114.64M63.87%
Dec 31, 2022179.48M-320.52M-64.10%
Dec 31, 2021500.00M422.20M542.70%
Dec 31, 202077.80M-48.32M-38.31%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ark Solutions 21.50B
PanGen Biotech 15.27B
HLB Pep 4.89B
SunBio,Inc. 2.17B
EyeGene 4.10B
Naturalendo Tech 21.87B
Aptamer Sciences 1.08B
Shaperon 179.38M
Revenue Rankings